{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:56:46Z","timestamp":1787313406677,"version":"build-2736575974"},"reference-count":40,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Health Science and Technology Project of Zhejiang Province","award":["2018273130"],"award-info":[{"award-number":["2018273130"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Ovarian clear cell carcinoma (OCCC) is a special histological type of epithelial ovarian cancer (EOC) that is not derived from epithelial cells of the ovarian or fallopian tube as the most common type of ovarian cancer, high-grade serous ovarian carcinoma (HGSOC), but is closely related to endometriosis and similar to endometrial clear cell carcinoma (ECCC) at morphologic and phenotypic features. However, limited data was shown in OCCC genomic features and compared with that in OCCC, HGSOC and ECCC. Herein, we utilized next-generation sequencing analysis of a panel of 1,021 genes to profile the mutational alterations in 34 OCCC and compared them to those from HGSOC (402 cases) and ECCC (30 cases). In result, the ARID1A and PIK3CA are high-frequency mutations of OCCC. Clonal architectures showed that all the mutations of genes occur in the later stage in the OCCC progress, whereas KRAS mutation is the earlier event compared with mutation of ARID1A or PIK3CA, which usually occurs in a group of ARID1A or PIK3CA mutations. The mutation frequency of main driver genes is similar between OCCC and ECCC, while TP53 is the main mutation in HGSOC and ECCC. Shared mutational signatures between OCCC and ECCC tissues with commonly observed a C&gt;T change indicated a common carcinogens-exposed between these two carcinomas, but HGSOC and ECCC have common and distinct mutational signatures across cohorts respectively. In addition, we identified some novel CNV gains in NF1, ASXL1, TCF7L2, CREBBP and LRP1B and loss in ATM, FANCM, RB1 and FLT in OCCC. Our study offered a new perspective for OCCC tumorigenesis from two organs, the ovary and uterus, at genomic architectures and revealed novel CNV events for helping to provide theoretical support for OCCC treatment.<\/jats:p>","DOI":"10.7717\/peerj.14653","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T03:55:20Z","timestamp":1674705320000},"page":"e14653","source":"Crossref","is-referenced-by-count":9,"title":["Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues"],"prefix":"10.7717","volume":"11","author":[{"given":"Meifu","family":"Gan","sequence":"first","affiliation":[{"name":"Department of Pathology, Taizhou Hospital affiliated to Wenzhou Medical University,  Linhai, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixian","family":"Tai","sequence":"additional","affiliation":[{"name":"Geneplus Shenzhen, Shenzhen, Guangdong province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijian","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Taizhou Hospital affiliated to Wenzhou Medical University,  Linhai, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Geneplus Shenzhen, Shenzhen, Guangdong province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Taizhou Hospital affiliated to Wenzhou Medical University,  Linhai, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"10.7717\/peerj.14653\/ref-1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"10.7717\/peerj.14653\/ref-2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ygyno.2011.01.005","article-title":"Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010","volume":"121","author":"Anglesio","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.14653\/ref-3","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-associated mutations in endometriosis without cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"The New England Journal of Medicine"},{"key":"10.7717\/peerj.14653\/ref-4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/PAS.0000000000001209","article-title":"Targeted molecular and immunohistochemical analyses of endometrial clear cell carcinoma show that POLE mutations and DNA mismatch repair protein deficiencies are uncommon","volume":"43","author":"Baniak","year":"2019","journal-title":"The American Journal of Surgical Pathology"},{"issue":"3","key":"10.7717\/peerj.14653\/ref-5","doi-asserted-by":"publisher","first-page":"e001792","DOI":"10.1136\/jitc-2020-001792","article-title":"LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types","volume":"9","author":"Brown","year":"2021","journal-title":"The Journal for ImmunoTherapy of Cancer"},{"key":"10.7717\/peerj.14653\/ref-6","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1038\/ncomms7118","article-title":"Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling","volume":"6","author":"Chandler","year":"2015","journal-title":"Nature Communications"},{"key":"10.7717\/peerj.14653\/ref-7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/21541248.2016.1212689","article-title":"What makes oncogenes mutually exclusive?","volume":"8","author":"Cisowski","year":"2017","journal-title":"Small GTPases"},{"key":"10.7717\/peerj.14653\/ref-8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ygyno.2006.12.024","article-title":"Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary","volume":"105","author":"Crotzer","year":"2007","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.14653\/ref-9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000517372","article-title":"LRP1B expression as a putative predictor of response to pegylated liposomal doxorubicin treatment in ovarian cancer","volume":"88","author":"Dionisio de Sousa","year":"2021","journal-title":"Pathobiology"},{"key":"10.7717\/peerj.14653\/ref-10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/path.4947","article-title":"The genetic landscape of endometrial clear cell carcinomas","volume":"243","author":"DeLair","year":"2017","journal-title":"Journal of Pathology"},{"key":"10.7717\/peerj.14653\/ref-11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3109\/09513590.2014.926325","article-title":"Novel insights on the malignant transformation of endometriosis into ovarian carcinoma","volume":"30","author":"Gadducci","year":"2014","journal-title":"Gynecological Endocrinology"},{"key":"10.7717\/peerj.14653\/ref-12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"10.7717\/peerj.14653\/ref-13","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.7150\/jca.56135","article-title":"CREBBP knockdown suppressed proliferation and promoted chemo-sensitivity via PERK-mediated unfolded protein response in ovarian cancer","volume":"12","author":"Hu","year":"2021","journal-title":"Journal of Cancer"},{"key":"10.7717\/peerj.14653\/ref-14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gcc.22918","article-title":"Analysis of mutational signatures with yet another package for signature analysis","volume":"60","author":"Hubschmann","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.7717\/peerj.14653\/ref-15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0090-8258(89)90852-4","article-title":"Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma","volume":"32","author":"Jenison","year":"1989","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.14653\/ref-16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/PGP.0000000000000430","article-title":"Morphologic and immunohistochemical study of clear cell carcinoma of the uterine endometrium and cervix in comparison to ovarian clear cell carcinoma","volume":"37","author":"Ju","year":"2018","journal-title":"The International Journal of Gynecological Pathology"},{"key":"10.7717\/peerj.14653\/ref-17","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.3802\/jgo.2021.32.e3","article-title":"Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma","volume":"32","author":"Jung","year":"2021","journal-title":"Journal of Gynecologic Oncology"},{"key":"10.7717\/peerj.14653\/ref-18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/modpathol.2011.161","article-title":"Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma","volume":"25","author":"Katagiri","year":"2012","journal-title":"Modern Pathology"},{"key":"10.7717\/peerj.14653\/ref-19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.humpath.2018.11.013","article-title":"PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features","volume":"86","author":"Kato","year":"2019","journal-title":"Human Pathology"},{"key":"10.7717\/peerj.14653\/ref-20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ygyno.2017.12.005","article-title":"Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing","volume":"148","author":"Kim","year":"2018","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.14653\/ref-21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/GCO.0000000000000340","article-title":"Pathogenesis and heterogeneity of ovarian cancer","volume":"29","author":"Kroeger Jr","year":"2017","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.7717\/peerj.14653\/ref-22","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2353\/ajpath.2009.081000","article-title":"Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma","volume":"174","author":"Kuo","year":"2009","journal-title":"The American Journal of Pathology"},{"key":"10.7717\/peerj.14653\/ref-23","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/bioinformatics\/bts146","article-title":"CONTRA: copy number analysis for targeted resequencing","volume":"28","author":"Li","year":"2012","journal-title":"Bioinformatics"},{"key":"10.7717\/peerj.14653\/ref-24","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/PAS.0000000000000436","article-title":"Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma","volume":"39","author":"Lim","year":"2015","journal-title":"The American Journal of Surgical Pathology"},{"key":"10.7717\/peerj.14653\/ref-25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ygyno.2019.03.243","article-title":"Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: a JSGO-JSOG joint study","volume":"153","author":"Machida","year":"2019","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.14653\/ref-26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ygyno.2016.11.045","article-title":"Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis","volume":"144","author":"Maru","year":"2017","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.14653\/ref-27","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Research"},{"key":"10.7717\/peerj.14653\/ref-28","doi-asserted-by":"publisher","first-page":"e11177","DOI":"10.15252\/emmm.201911177","article-title":"Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer","volume":"12","author":"Moyano-Galceran","year":"2020","journal-title":"EMBO Molecular Medicine"},{"key":"10.7717\/peerj.14653\/ref-29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ygyno.2011.10.001","article-title":"The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations","volume":"124","author":"Munksgaard","year":"2012","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.14653\/ref-30","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1016\/j.ajpath.2017.06.012","article-title":"Exome sequencing landscape analysis in ovarian clear cell carcinoma shed light on key chromosomal regions and mutation gene networks","volume":"187","author":"Murakami","year":"2017","journal-title":"The American Journal of Pathology"},{"issue":"20","key":"10.7717\/peerj.14653\/ref-31","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.3390\/cancers13205242","article-title":"Genomic sub-classification of ovarian clear cell carcinoma revealed by distinct mutational signatures","volume":"13","author":"Oliveira","year":"2021","journal-title":"Cancers"},{"key":"10.7717\/peerj.14653\/ref-32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/uog.19171","article-title":"Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma","volume":"52","author":"Pozzati","year":"2018","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"key":"10.7717\/peerj.14653\/ref-33","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","article-title":"Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy","volume":"88","author":"Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"10.7717\/peerj.14653\/ref-34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1756-9966-31-53","article-title":"Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?","volume":"31","author":"Takano","year":"2012","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.7717\/peerj.14653\/ref-35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/his.13976","article-title":"Clear cell endometrial carcinoma and the TCGA classification","volume":"76","author":"Travaglino","year":"2020","journal-title":"Histopathology"},{"key":"10.7717\/peerj.14653\/ref-36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/PGP.0000000000000207","article-title":"Molecular alterations of TP53 are a defining feature of ovarian high-grade serous carcinoma: a rereview of cases lacking TP53 mutations in the cancer genome atlas ovarian study","volume":"35","author":"Vang","year":"2016","journal-title":"International Journal of Gynecological Pathology"},{"key":"10.7717\/peerj.14653\/ref-37","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1111\/liv.14463","article-title":"Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma","volume":"40","author":"Wang","year":"2020","journal-title":"Liver International"},{"key":"10.7717\/peerj.14653\/ref-38","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.7717\/peerj.14653\/ref-39","first-page":"65","article-title":"WHO classification of tumours","volume-title":"Female genital tumours","author":"WHO Classification of Tumours Editorial Board","year":"2020","edition":"5"},{"key":"10.7717\/peerj.14653\/ref-40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/modpathol.2011.189","article-title":"Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations","volume":"25","author":"Yamamoto","year":"2012","journal-title":"Modern Pathology"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/14653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/14653.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/14653.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/14653.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T03:55:29Z","timestamp":1674705329000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/14653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":40,"alternative-id":["10.7717\/peerj.14653"],"URL":"https:\/\/doi.org\/10.7717\/peerj.14653","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"article-number":"e14653"}}